Efficacy of IPX066 for Japanese Parkinson's disease patients. Open trial

Efficacy of IPX066 for Japanese Parkinson's disease patients. Open trial - IPX066 for Japanese PD patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021561

Enrollment

Registered

2016-05-01

Start date

2016-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

2 years application of Rytary with 95 mg/23.75 mg or 145 mg/36.25 mg or 195 mg/48.75 mg or 245 mg/61.25 mg

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Parkinson's disease patients

Exclusion criteria

Exclusion criteria: Patients with parkinson syndrome

Design outcomes

Primary

Measure	Time frame
the change of on and off time percentage while awake,	—

Secondary

Measure	Time frame
UPDRS motor score	—

Countries

Japan

Contacts

Public ContactYasushi Shimo

Juntendo University School of Medicine Department of Neurology

yshimo@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

Efficacy of IPX066 for Japanese Parkinson&#39;s disease patients. Open trial